Search
Rosario Costas-Muñiz’s work is helping Latino patients at MSK and across Latin America.
El trabajo de Rosario Costas-Muñiz ayuda a pacientes latinos en MSK y en toda América Latina.
Craig B. Thompson, MD, has been named the new President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center effective November 2, 2010. His appointment concludes a search that began in January 2010.
Research recently published by MSK scientists suggests that the best way to fight dangerous bacteria may be with other bacteria.
A new study by a team of 12 thoracic surgeons at Memorial Sloan Kettering Cancer Center (MSK), published recently in the Annals of Surgery,([i]) is the first to identify a comprehensive list of clinical factors significantly associated with referring patients with stage 1 NSCLC to SBRT.
A newly identified group of immunosuppressive cells could provide insight into the effects of immunotherapy drugs.
A commentary by members of Memorial Sloan Kettering Cancer Center’s (MSK) Bobst International Center along with members of the Bloomberg New Economy International Cancer Coalition (the “Coalition”) calls for global collaboration to reimagine patient-centric cancer clinical trials. The piece was published in the April 19, 2022, “The Future of Cancer Research” special Focus edition of the journal Nature Medicine.
After graduate student Irene Dimatulac was diagnosed with osteosarcoma in her knee, treatment at MSK — and support from MSK’s Adolescent and Young Adult Program — allowed her to get back to her life.
Después de que a la estudiante de posgrado Irene Dimatulac le diagnosticaran osteosarcoma en la rodilla, el tratamiento en MSK —y el apoyo del Programa para Adolescentes y Adultos Jóvenes de MSK— le permitieron volver a su vida.
Scott Callahan is the second Gerstner Sloan Kettering student to receive the Joanna M. Nicolay Melanoma Foundation grant, which supports exceptional melanoma research by graduate students.